BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Free NanoSight Limited Webinar on the Use of Nanoparticle Tracking Analysis in Drug Delivery Research


5/29/2013 11:26:08 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Salisbury, UK, 29th May 2013: NanoSight, leading manufacturers of unique nanoparticle characterization technology, will address the challenges of nanoparticle control and analysis in the latest of their popular webinar program. This will be held on Thursday 6th June.

On Thursday 6th June at 1530 and 1730 BST time (1030 & 1230 EDT), NanoSight will host a webinar to look at how Nanoparticle Tracking Analysis (NTA) is used to as a characterization tool during the development of drug delivery systems. NanoSight will:

• Discuss drug delivery systems, what’s available and the advantages of nanoparticles.

• Briefly introduce those unfamiliar to NTA to this technology and the data it provides.

• Present recent data on the use of NTA in characterizing drug delivery systems of liposomes, polymer carriers and for prodrugs.

Drug delivery applications are attractive option as they have the potential to allow a medicine to preferentially act at the site of disease and have reduced side effects. The webinar will discuss how nano-scale therapeutics are particularly suited for drug delivery and what types are available. Particle size is a key parameter when characterizing nano-particles. NTA has been used in the research of drug delivery systems of liposomes, polymer carriers and prodrugs. This webinar will be of particular interest to those working in drug and biotherapeutics research, development and formulation, from Project Managers to Bench Scientists.

The webinar will be led by Pauline Carnell (Senior Applications Scientist) and Jeremy Warren (CEO). The webinar will be both informative and interactive. Register now and join in the discussions on this important issue: www.nanosight.com/webinar . It will also be available for viewing after the live event. The link will be the same.

To find out about the company and to learn more about nanoparticle characterization using NanoSight's unique nanoparticle tracking analysis solutions, visit http://www.nanosight.com/ and register to receive the next issue of NanoTrail, the company's electronic newsletter.

About NanoSight:

NanoSight delivers the world’s most versatile and proven multi-parameter nanoparticle analysis in a single instrument. NanoSight’s “Nanoparticle Tracking Analysis” (NTA) detects and visualizes populations of nanoparticles in liquids down to 10 nm, dependent on material, and measures the size of each particle from direct observations of diffusion. Additionally, NanoSight measures concentration and a fluorescence mode differentiates suitably-labelled particles within complex background suspensions. Zeta potential measurements are similarly particle-specific. It is this particle-by-particle methodology that takes NTA beyond traditional light scattering and other ensemble techniques in providing high-resolution particle size distributions and validates data with information-rich video files of the particles moving under Brownian motion.

This simultaneous multiparameter characterization matches the demands of complex biological systems, hence its wide application in development of drug delivery systems, of viral vaccines, and in nanotoxicology. This real-time data gives insight into the kinetics of protein aggregation and other time-dependent phenomena in a qualitative and quantitative manner. NanoSight has a growing role in biodiagnostics, being proven in detection and speciation of nanovesicles (exosomes) and microvesicles.

NanoSight has installed more than 600 systems worldwide with users including BASF, GlaxoSmithKline, Merck, Novartis, Pfizer, Proctor and Gamble, Roche and Unilever together with the most eminent universities and research institutes. NanoSight’s technology is validated by 800+ third party papers citing NanoSight results. NanoSight’s leadership position in nanoparticle characterization is consolidated further with publication of an ASTM International standard, ASTM E2834, which describes the NTA methodology for detection and analysis of nanoparticles. For more information, visit http://www.nanosight.com/.

For further information:

Please contact NanoSight direct or their marketing agency, Talking Science Limited:

NanoSight Limited

Minton Park

London Road

Amesbury SP4 7RT UK

T +44(0)1980 676060

F +44(0)1980 624703

http://www.nanosight.com/

sarah.newell@nanosight.com

Talking Science Limited

39 de Bohun Court

Saffron Walden

Essex CB10 2BA UK

T +44(0)1799 521881

M +44(0)7843 012997

http://www.talking-science.com/

jezz@talking-science.com



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES